Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-05-03
1998-03-10
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462767, A61K 3144
Patent
active
057261890
ABSTRACT:
The present invention is directed to radiolabeled epibatidine analogues, specifically FPH labeled with radioisotopes of fluorine and/or carbon. These radiolabeled epibatidine compounds are used to noninvasively image and quantify nicotinic cholinergic receptors in the living brain for both research studies and the diagnosis of neurodegenerative diseases.
REFERENCES:
patent: 3932429 (1976-01-01), Takeda et al.
patent: 4499099 (1985-02-01), Watts
patent: 4985063 (1991-01-01), Fischer et al.
patent: 5015655 (1991-05-01), Galliani et al.
patent: 5314899 (1994-05-01), Daly et al.
patent: 5462956 (1995-10-01), Daly et al.
!-2.beta.-Carbomethoxy-3.beta.-(4-iodophenyl)tropane: High-Affinity SPECT Radiotracer of Monoamine Reuptake Sites In Brain, J. Med. Chem., 34:3144-3146 (1991).
Sieby, John P., et al., Reproducibility of Iodine-123-.beta.-CIT SPECT Brain Measurement of Dopamine Transporters, J. of Nuclear Med., 37:222-228, (1996).
Laruelle, Marc, et al., Spect Imaging of Dopamine and Serotonin Tramporters in Nonhuman Primates, Synapse, 13:295-309, (1993). Radioligand for Quantitation of the Dopamine Transporter: Preparation, Autoradiography, Metabolite Studies, and Positron Emission Tomography Examinations, Nucl. Med. Bio., 22:905-913 (1995).
Dagami, Ron, Cocaine Analog for Parkinsonism Studies, Chem. & Eng. News, p.25-26, Oct. 14,1991.
CA 125:11186 Horti et al 1996.
CA 124:199570, Warpman et al 1995.
CA 123:236612, Haughtling et al 1995.
Badio et al., Epibatidine, a Potent Analgetic and Nicotinic Agonist; Molecular Pharmacology, 45:563-569 (1994).
Nyback et al., Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography; Progress in Brain Research, Nordberg et al. (Ed.), 79:313-19 (1989).
London et al., Nictinic Binding Sites in Cerebral Cortex and Hippocampus in Alzheimer's Dementia, Neurochemical Research, 14:745-750 (1989).
London et al., In vivo labeling of nicotinic acetylcholine receptors in (1995) R1-R2.
Imaging Alzheimer'Science, 266:1810, Dec. 16,1994. Ligands for the Neuronal Nicotinic Receptor, Journal of Labelled Compounds and Radiopharmaceuticals, 37: 355-56 (1995) (abstract only).
Dannals Robert F.
Horti Andrew
Kassiou Michael
Kimes Alane S.
London Edythe D.
Fan Jane
Johns Hopkins University School of Medicine
The United States of America, represented by The Secretary, Depa
LandOfFree
Method for imaging nicotinic acetylcholinergic receptors in the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for imaging nicotinic acetylcholinergic receptors in the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for imaging nicotinic acetylcholinergic receptors in the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139862